- Home
- CAVA vs QGEN Comparison
CAVA vs QGEN Comparison
Compare CAVA & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAVA | QGEN |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.2B |
| IPO Year | 2023 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CAVA | QGEN |
|---|---|---|
| Price | $88.53 | $41.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 9 |
| Target Price | ★ $88.67 | $51.30 |
| AVG Volume (30 Days) | ★ 2.7M | 1.7M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 6.01% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,179,664,000.00 | N/A |
| Revenue This Year | $25.71 | $8.18 |
| Revenue Next Year | $20.50 | $5.71 |
| P/E Ratio | $154.50 | ★ $24.01 |
| Revenue Growth | ★ 22.41 | N/A |
| 52 Week Low | $43.41 | $38.80 |
| 52 Week High | $97.98 | $57.82 |
Technical Indicators
Market Signals| Indicator | CAVA | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 62.25 | 46.19 |
| Support Level | $62.15 | $38.80 |
| Resistance Level | $90.84 | $48.80 |
| Average True Range (ATR) | 4.42 | 0.83 |
| MACD | -0.13 | 0.45 |
| Stochastic Oscillator | 86.59 | 89.28 |
Price Performance
Historical ComparisonAbout CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).